Zeroing in on progeria: How mutant lamins cause premature agingDecember 14, 2005News from the Cell Biology Meeting in San Francisco Children diagnosed with Hutchinson-Gilford Progeria Syndrome (HGPS) race through life against an unfairly fast clock. Cases are extremely rare-one in 8 million births-but time plays cruel tricks on HGPS newborns. They begin life in apparent good health but by six-eighteen months develop the first signs of premature aging, including hair loss, stiff joints, osteoporosis and atherosclerosis. Typically, the HGPS race through life runs out by age 13, finished by heart attacks or strokes. But progeria researchers made a breakthrough in 2003, tracing HGPS to a spontaneous mutation in a gene encoding an important structural component of the cell nucleus, the organelle in which our DNA is stored, read out, and copied. As the so-called "Mothership of the Human Genome," the cell nucleus must keep all this vital genetic information safe but accessible inside a strong protective envelope. The inner membrane of the nuclear envelope is lined by tough but adaptable proteins called lamins. The mutated gene for HGPS affected the nuclear lamin A (LA) protein. The discovery that progeria was a "laminopathy," a disorder caused by a nuclear lamin failure, gave HGPS families new hope because it gave clinical researchers new targets for drug or other interventions. But the discovery gave cell biologists a new problem. If HGPS was cellular aging run wild, was it a warp-speed version of "normal" aging? If so, what was it about the mutated LA protein behind HGPS that causes cells to age so rapidly? In work presented Tuesday at the 45th Annual Meeting of the American Society for Cell Biology in San Francisco, Robert Goldman and his collaborators at the Northwestern University's Feinberg School of Medicine and elsewhere describe how they've zeroed in on the defective lamin A proteins linked to HGPS. While lamins polymerize into fibrous structures that hold up the "walls" of the nucleus, they also serve as an internal scaffold for the complex machinery involved in DNA replication and gene expression. It was in this later role that the researchers have been looking for clues to premature and possibly to normal aging. Reporting on two sets of experiments, Goldman et al say that the mutant LA protein seems to interfere with key controls of gene expression and of the cell cycle. The first study discovered that the most common HGPS-linked mutant LA protein alters the organization of regions of chromosomes that are critically important in regulating gene expression. These so-called heterochromatic regions include the inactive X (Xi) chromosome found in normal female cells. One of the hallmarks of Xi heterochromatin is its association with proteins known as methylated histones. In the cells from a female HGPS patient, the researchers found that levels of this molecular hallmark and of an enzyme required for histone methylation of Xi are sharply lower. The second set of results reveals mutant LA proteins turning up in the wrong place-too tightly linked to the membranes of the nuclear envelope-to be of much help during key stages of the cell cycle. The researchers believe that this localization failure of mutated LA proteins would severely compromise the ability of HGPS cells to engage in normal DNA replication, a probable factor in their rapid march to premature senescence. Whether similar missteps and miscues by nuclear lamins are part of "normal" human aging is the question that draws researchers onward, says Goldman. American Society for Cell Biology |
|||||||||||||||||||||
| Related Progeria Current Events and Progeria News Articles Effects of smoking linked to accelerated aging protein A University of Iowa study is apparently the first to make a connection between a rare, hereditary premature aging disease and cell damage that comes from smoking. The study results point to possible therapeutic targets for smoking-related diseases. Anti-cancer drug prevents, reverses cardiovascular damage in mouse model of premature aging disorder An experimental anti-cancer drug can prevent -- and even reverse -- potentially fatal cardiovascular damage in a mouse model of progeria, a rare genetic disorder that causes the most dramatic form of human premature aging, National Institutes of Health (NIH) researchers reported today. Adult stem cell changes underlie rare genetic disease associated with accelerated aging Adult stem cells may provide an explanation for the cause of a Hutchinson-Gilford Progeria Syndrome (HGPS), a rare disease that causes premature aging in children, according to researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH). Stanford/Packard researchers find disease genes hidden in discarded data Previously hidden obesity-related genes have been uncovered from old experiments by researchers at the Stanford University School of Medicine and Lucile Packard Children's Hospital. The finding suggests that useful information about many medical disorders may be languishing in mountains of discarded data. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus UCLA scientists, along with collaborators from Purdue University, have demonstrated that HIV protease inhibitors - crucial drugs for HIV treatment - block a cellular enzyme important for generating the structural scaffolding for the cell nucleus. New clues for treatment of disease that causes accelerated aging There is renewed hope for treatment of a rare genetic condition that causes rapidly accelerated aging and leads to an average life expectancy of 13 years. Carnegie Mellon researchers discover new cell properties Carnegie Mellon University researchers Kris Noel Dahl and Mohammad F. Islam have made a new breakthrough for children suffering from an extremely rare disease that accelerates the aging process by about seven times the normal rate. UCLA finds cancer drug may improve progeria; genetic disease causes accelerated aging in children UCLA researchers found that an experimental cancer drug improves the signs of progeria in a mouse model. Progeria is a rare genetic disease causing accelerated aging and cardiovascular disease in children. Anti-cancer drugs may hold promise for premature aging disorder In a surprising development, a research team led by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has found that a class of experimental anti-cancer drugs also shows promise in laboratory studies for treating a fatal genetic disorder that causes premature aging. Blocking a premature aging syndrome with anticancer drugs A class of anticancer drugs currently being evaluated in phase 3 clinical trials may also be an effective treatment for Hutchinson-Gilford progeria syndrome (HGPS), a fatal genetic disorder that causes premature aging. More Progeria Current Events and Progeria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||